Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

被引：155

作者：

Wang, Li-Tzu ^{[1
,2
]}

Ting, Chiao-Hsuan ^{[1
]}

Yen, Men-Luh ^{[3
,4
]}

Liu, Ko-Jiunn ^{[5
]}

Sytwu, Huey-Kang ^{[2
,6
]}

Wu, Kenneth K. ^{[1
,7
]}

Yen, B. Linju ^{[1
]}

机构：

[1] Natl Hlth Res Inst, Inst Cellular & Syst Med, Regenerat Med Res Grp, 35 Keyan Rd, Zhunan 35053, Taiwan

[2] NDMC, Grad Inst Life Sci, Taipei, Taiwan

[3] Natl Taiwan Univ Hosp, Dept Ob Gyn, Taipei, Taiwan

[4] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[5] NHRI, Natl Inst Canc Res, Tainan, Taiwan

[6] NDMC, Grad Inst Microbiol & Immunol, Taipei, Taiwan

[7] China Med Coll, Grad Inst Basic Med Sci, Taichung, Taiwan

来源：

JOURNAL OF BIOMEDICAL SCIENCE | 2016年 / 23卷

关键词：

Mesenchymal stem cells; Human; Immunomodulation; Inflammation; Clinical trials; Autoimmune disease; Organ transplantation and rejection; Stem cell therapy; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALLERGIC AIRWAY INFLAMMATION; DSS-INDUCED COLITIS; STROMAL CELLS; MOUSE MODEL; CROHNS-DISEASE; IN-VITRO; LYMPHOCYTE-PROLIFERATION;

D O I：

10.1186/s12929-016-0289-5

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that have been shown to possess immunomodulatory properties in recent years. Initially met with much skepticism, MSC immunomodulation has now been well reproduced across tissue sources and species to be clinically relevant. This has opened up the use of these versatile cells for application as 3rd party/allogeneic use in cell replacement/tissue regeneration, as well as for immune-and inflammation-mediated disease entities. Most surprisingly, use of MSCs for in immune-/inflammation-mediated diseases appears to yield more efficacy than for regenerative medicine, since engraftment of the exogenous cell does not appear necessary. In this review, we focus on this non-traditional clinical use of a tissue-specific stem cell, and highlight important findings and trends in this exciting area of stem cell therapy.

引用

页码：1 / 13

页数：13

共 148 条

[71] Targeting Improves MSC Treatment of Inflammatory Bowel Disease [J].

Ko, In Kap ;

Kim, Byung-Gyu ;

Awadallah, Amad ;

Mikulan, Jenifer ;

Lin, Paul ;

Letterio, John J. ;

Dennis, James E. .

MOLECULAR THERAPY, 2010, 18 (07) :1365-1372

[72] Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy [J].

Koç, ON ;

Gerson, SL ;

Cooper, BW ;

Dyhouse, SM ;

Haynesworth, SE ;

Caplan, AI ;

Lazarus, HM .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :307-316

[73] Adult stem cells for tissue repair - A new therapeutic concept? [J].

Korbling, M ;

Estrov, Z .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :570-582

[74] Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37 [J].

Krasnodembskaya, Anna ;

Song, Yuanlin ;

Fang, Xiaohui ;

Gupta, Naveen ;

Serikov, Vladimir ;

Lee, Jae-Woo ;

Matthay, Michael A. .

STEM CELLS, 2010, 28 (12) :2229-2238

[75] Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients [J].

Kurtzberg, Joanne ;

Prockop, Susan ;

Teira, Pierre ;

Bittencourt, Henrique ;

Lewis, Victor ;

Chan, Ka Wah ;

Horn, Biljana ;

Yu, Lolie ;

Talano, Julie-An ;

Nemecek, Eneida ;

Mills, Charles R. ;

Chaudhury, Sonali .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) :229-235

[76] Mouse Mesenchymal Stem Cells Suppress Antigen-Specific TH Cell Immunity Independent of Indoleamine 2,3-Dioxygenase 1 (IDO1) [J].

Lanz, Tobias V. ;

Opitz, Christiane A. ;

Ho, Peggy P. ;

Agrawal, Ankur ;

Lutz, Christian ;

Weller, Michael ;

Mellor, Andrew L. ;

Steinman, Lawrence ;

Wick, Wolfgang ;

Platten, Michael .

STEM CELLS AND DEVELOPMENT, 2010, 19 (05) :657-668

[77] Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells [J].

Le Blanc, K ;

Rasmusson, I ;

Sundberg, B ;

Götherström, C ;

Hassan, M ;

Uzunel, M ;

Ringdén, O .

LANCET, 2004, 363 (9419) :1439-1441

[78] Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex [J].

Le Blanc, K ;

Tammik, L ;

Sundberg, B ;

Haynesworth, SE ;

Ringdén, O .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (01) :11-20

[79] Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study [J].

LeBlanc, Katarina ;

Frassoni, Francesco ;

Ball, Lynne ;

Locatelli, Franco ;

Roelofs, Helene ;

Lewis, Ian ;

Lanino, Edoardo ;

Sundberg, Berit ;

Bernardo, Maria Ester ;

Remberger, Mats ;

Dini, Giorgio ;

Egeler, R. Maarten ;

Bacigalupo, Andrea ;

Fibbe, Willem ;

Ringden, Olle .

LANCET, 2008, 371 (9624) :1579-1586

[80] Therapeutic Effects of Human Mesenchymal Stem Cells in Ex Vivo Human Lungs Injured with Live Bacteria [J].

Lee, Jae W. ;

Krasnodembskaya, Anna ;

McKenna, David H. ;

Song, Yuanlin ;

Abbott, Jason ;

Matthay, Michael A. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (07) :751-760

← 3 4 5 6 7 8 9 10 11 12 →